Macrophage blockade using nature-inspired ferrihydrite for enhanced nanoparticle delivery to tumor

• Published in: International journal of pharmaceutics 2022-06, Vol.621, p.121795-121795, Article 121795
• Main Authors: Mirkasymov, Aziz B., Zelepukin, Ivan V., Ivanov, Ilya N., Belyaev, Iaroslav B., Sh. Dzhalilova, Dzhuliia, Trushina, Daria B., Yaremenko, Alexey V., Yu. Ivanov, Vsevolod, Nikitin, Maxim P., Nikitin, Petr I., Zvyagin, Andrei V., Deyev, Sergey M.
• Format: Article
• Language: English
• Subjects: Biodistribution; Ferrihydrite; Magnetic nanoparticles; Mononuclear phagocyte system; Pharmacokinetics; Toxicity
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2022.121795

[Display omitted] The rapid elimination of systemically administered drug nanocarriers by the mononuclear phagocyte system (MPS) compromises nanomedicine delivery efficacy. To mitigate this problem, an approach to block the MPS has been introduced and implemented by intravenous pre-administering blocker nanoparticles. The required large doses of blocker nanoparticles appeared to burden the MPS, raising toxicity concerns. To alleviate the toxicity issues in MPS blockade, we propose an intrinsically biocompatible blocker, ferrihydrite – a metabolite ubiquitous in a biological organism. Ferrihydrite particles were synthesized to mimic endogenous ferritin-bound iron. Ferrihydrite surface coating with carboxymethyl-dextran was found to improve MPS blockade dramatically with a 9-fold prolongation of magnetic nanoparticle circulation in the bloodstream and a 24-fold increase in the tumor targeted delivery. The administration of high doses of ferrihydrite caused low toxicity with a rapid recovery of toxicological parameters after 3 days. We believe that ferrihydrite particles coated with carboxymethyl-dextran represent superior blocking biomaterial with enviable biocompatibility.